文献速递关节外科

非设计者研究者对四种全踝关节置换假体的前瞻性研究

A Prospective Study of Four Total Ankle Arthroplasty Implants by Non-Designer Investigators.
PubMed 文献 · J Bone Joint Surg Am · 2017-01-01

该前瞻性研究纳入451例全踝关节置换术,平均随访4.5±2.0年,比较Hintegra、Agility、Mobility和STAR四种假体的临床与功能结局。Mobility假体的踝关节骨关节炎量表(AOS)总分、疼痛和残疾评分平均改善均小于其他三种假体,至少三种假体(Hintegra、STAR和Agility)的患者报告评分结果相当。

要点

  • Mobility假体AOS总分平均改善19.5(95%CI 15-24),低于Agility的29.1、Hintegra的29.7和STAR的28.5。
  • Mobility组AOS疼痛评分改善21.3,低于Hintegra的29.0、Agility的29.8和STAR的29.1。
  • Mobility组AOS残疾评分改善17.3,低于Hintegra的30.4、Agility的28.8和STAR的27.8。

核心结论

  • 本研究显示4种现代全踝关节置换假体可获得可接受的结局,至少3种假体(Hintegra、STAR和Agility)的患者报告评分结果相当。
  • 本研究报告的并发症和翻修率在文献报道的同类假体和报告方法的范围内。

研究设计与样本

  • 前瞻性招募患者,共纳入451例全踝关节置换术,平均随访4.5±2.0年。
  • 每年评估患者并完成自我报告结局测量,并发症和翻修在事件发生时报告。
  • 使用线性混合效应模型对假体间评分进行校正比较,并按假体和并发症类型生成生存曲线。

主要发现

  • Mobility假体AOS总分平均改善19.5(95%CI 15至24),低于Agility的29.1(95%CI 24至34)、Hintegra的29.7(95%CI 27至33)和STAR的28.5(95%CI 23至34)。
  • Mobility组AOS疼痛评分平均改善21.3(95%CI 17至26),低于Hintegra的29.0(95%CI 26至32)、Agility的29.8(95%CI 25至35)和STAR的29.1(95%CI 23至35)。
  • Mobility组AOS残疾评分平均改善17.3(95%CI 12至23),低于Hintegra的30.4(95%CI 27至34)、Agility的28.8(95%CI 23至34)和STAR的27.8(95%CI 21至34)。
  • 报告了4种假体的生存结果。

关键数值与推荐

  • Mobility假体AOS总分平均改善19.5(95%CI 15至24),Agility为29.1(95%CI 24至34),Hintegra为29.7(95%CI 27至33),STAR为28.5(95%CI 23至34)。
  • Mobility假体AOS疼痛评分平均改善21.3(95%CI 17至26),Hintegra为29.0(95%CI 26至32),Agility为29.8(95%CI 25至35),STAR为29.1(95%CI 23至35)。
  • Mobility假体AOS残疾评分平均改善17.3(95%CI 12至23),Hintegra为30.4(95%CI 27至34),Agility为28.8(95%CI 23至34),STAR为27.8(95%CI 21至34)。
  • 证据等级为治疗性II级。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There are several types of prostheses available to surgeons when performing a total ankle arthroplasty (TAA). The main objective of this study was to summarize the clinical and functional outcomes of 4 TAA prostheses: the Hintegra implant (Integra LifeSciences), the Agility implant (DePuy), the Mobility implant (DePuy), and the Scandinavian Total Ankle Replacement (STAR) implant (Small Bone Innovations [SBi]). METHODS: Patients were prospectively recruited. A total of 451 TAAs with a mean follow-up (and standard deviation) of 4.5 ± 2.0 years were included. Patients were assessed annually and completed self-reported outcome measures at these visits. Complications and revisions were reported at the time of incident. Mean improvements are reported by prosthesis. Linear mixed-effects models were used to obtain adjusted comparisons of scores across prostheses. Survivorship curves were generated by prosthesis and type of complication. RESULTS: Mean improvement in the Ankle Osteoarthritis Scale (AOS) total score was less among patients with the Mobility implant (19.5; 95% confidence interval [CI], 15 to 24) than it was among patients with the Agility implant (29.1; 95% CI, 24 to 34), Hintegra implant (29.7; 95% CI, 27 to 33), and STAR implant (28.5; 95% CI, 23 to 34). Patients in the Mobility group also had less mean improvement in the AOS pain score (21.3; 95% CI, 17 to 26) compared with patients in the Hintegra (29.0; 95% CI, 26 to 32), Agility (29.8; 95% CI, 25 to 35), and STAR (29.1; 95% CI, 23 to 35) groups. The Mobility group also had less mean improvement in the AOS disability score (17.3; 95% CI, 12 to 23) compared with the Hintegra (30.4; 95% CI, 27 to 34), Agility (28.8; 95% CI, 23 to 34), and STAR (27.8; 95% CI, 21 to 34) groups. Survival results among the 4 prostheses are reported. CONCLUSIONS: This study demonstrated acceptable outcomes of 4 modern TAA prostheses. Outcome results from patient-reported scores were comparable between at least 3 of the 4 prostheses (the Hintegra, STAR, and Agility implants). The rates of complications and revisions found in this study are within the limits reported in the literature for similar prostheses and methods of reporting. LEVEL OF EVIDENCE: Therapeutic Level II. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Lefrancois T, Younger A, Wing K, et al. A Prospective Study of Four Total Ankle Arthroplasty Implants by Non-Designer Investigators. J Bone Joint Surg Am. 2017. PMID: 28196036. doi:10.2106/JBJS.16.00097

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。